Overview

This repository contains a comprehensive competitive landscape and treatment pathway analysis of Multiple Myeloma in the U.S. oncology market.
Multiple Myeloma is treated as a chronic, relapsing disease, where treatment sequencing, transplant eligibility, and immunotherapy adoption drive long-term value and patient outcomes.

ðŸ“„ Source File: Competitive Landscape on Multiple Myeloma 

Competitive Intelligence on Mulâ€¦

ðŸŽ¯ Objectives of the Analysis

Map treatment pathways across transplant-eligible, transplant-ineligible, and relapsed/refractory patients

Analyze market sizing and patient segmentation

Understand the shift from triplet to quadruplet regimens

Evaluate the strategic role of monoclonal antibodies, CAR-T, bispecifics, and ADCs

Identify future value pools in advanced-line therapies

ðŸ§  Key Strategic Insights

Multiple Myeloma is managed as a long-term chronic disease with repeated relapses

Early depth of response and autologous stem cell transplant (ASCT) define long first remissions

Frontline therapy is shifting from triplets â†’ quadruplets, driven by anti-CD38 antibodies

Relapsed/Refractory value creation is moving toward CAR-T and bispecific antibodies

Advanced immunotherapies command very high per-patient value despite smaller populations

ðŸ“Š Market & Patient Overview

~170,000 diagnosed and treated Multiple Myeloma patients in the U.S.

Clear segmentation by:

Transplant-eligible vs non-eligible patients

Frail vs non-frail at relapse

Significant cost differentiation across therapy classes:

Monoclonal antibodies

Bispecific antibodies

CAR-T cell therapies

ADCs

ðŸ’‰ Therapy Classes Covered

Proteasome Inhibitors (BTZ, CFZ, IXZ)

IMiDs (Lenalidomide, Pomalidomide, Thalidomide)

Anti-CD38 antibodies (Daratumumab, Isatuximab)

CAR-T therapies (BCMA-targeted)

Bispecific antibodies (BCMA Ã— CD3, GPRC5D Ã— CD3)

Antibodyâ€“Drug Conjugates (BCMA ADCs)

ðŸ§  Strategic Use Cases

Pharma product strategy & portfolio planning

Competitive intelligence and lifecycle management

Consulting case preparation

Oncology market deep-dive

Business Analyst / Product Manager portfolio showcase
